At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 18 Dec 1996 New profile
- 18 Dec 1996 Discontinued-Preclinical for Cancer in United Kingdom (Unknown route)